Researchers can use genome sequencing to figure out which microbes live in our guts or in the biofilms on our teeth or our implanted devices. But it’s much harder to figure out exactly where those microbes are, or how their distribution is changing over time. Kanvas’s founders invented a system that uses barcoded fluorescent probes and machine learning classification to map microbial communities in the gut and the mouth. The company plans to use the technique to find new ways to exploit the microbiome to improve health human, including developing novel therapeutics, understanding better how drugs are metabolized in the gut, and providing better diagnostic insights into infectious disease.
News & Insights
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules
Using synthetic biology to manufacture carbon-negative materials